ArticleFrontiers in immunology2018

Is It Safe to Switch From Intravenous Immunoglobulin to Subcutaneous Immunoglobulin in Patients With Common Variable Immunodeficiency and Autoimmune Thrombocytopenia?

Philipp Scheuerlein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.